Kyle Furge

4.5k total citations
20 papers, 1.0k citations indexed

About

Kyle Furge is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kyle Furge has authored 20 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kyle Furge's work include Cancer Genomics and Diagnostics (6 papers), Renal cell carcinoma treatment (4 papers) and Liver physiology and pathology (3 papers). Kyle Furge is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Renal cell carcinoma treatment (4 papers) and Liver physiology and pathology (3 papers). Kyle Furge collaborates with scholars based in United States, China and Singapore. Kyle Furge's co-authors include Bin Tean Teh, Karl Dykema, Ximing J. Yang, Charlotta Lindvall, Hongyu Liu, Dorine Bonte, Michael Weinreich, George F. Vande Woude, Chao Qian and Steven G. Gray and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer.

In The Last Decade

Kyle Furge

20 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyle Furge United States 18 645 368 286 224 111 20 1.0k
Chuifeng Fan China 20 694 1.1× 331 0.9× 238 0.8× 366 1.6× 100 0.9× 77 1.2k
Jana Krošl Canada 24 1.3k 2.1× 257 0.7× 190 0.7× 435 1.9× 86 0.8× 38 2.1k
Miki Hashimura Japan 23 731 1.1× 132 0.4× 255 0.9× 396 1.8× 118 1.1× 56 1.4k
Phillip J. Iaquinta United States 10 816 1.3× 439 1.2× 288 1.0× 556 2.5× 134 1.2× 11 1.3k
Debora Rasio Italy 16 876 1.4× 146 0.4× 352 1.2× 467 2.1× 81 0.7× 25 1.4k
Kanji Hojo Japan 11 560 0.9× 93 0.3× 261 0.9× 242 1.1× 85 0.8× 21 974
Victor Stastny United States 15 917 1.4× 141 0.4× 324 1.1× 443 2.0× 169 1.5× 24 1.4k
Kiyomi O. Toyooka United States 13 1.5k 2.4× 422 1.1× 318 1.1× 319 1.4× 48 0.4× 13 1.8k
R. V. Larocca United States 9 295 0.5× 227 0.6× 230 0.8× 204 0.9× 76 0.7× 19 813
Abdullah Mahmood Ali United States 20 1.5k 2.3× 90 0.2× 309 1.1× 244 1.1× 181 1.6× 60 2.0k

Countries citing papers authored by Kyle Furge

Since Specialization
Citations

This map shows the geographic impact of Kyle Furge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle Furge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle Furge more than expected).

Fields of papers citing papers by Kyle Furge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle Furge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle Furge. The network helps show where Kyle Furge may publish in the future.

Co-authorship network of co-authors of Kyle Furge

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle Furge. A scholar is included among the top collaborators of Kyle Furge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle Furge. Kyle Furge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Qian, Yingchun Su, Karl Dykema, et al.. (2013). Overexpression of HGF Promotes HBV-Induced Hepatocellular Carcinoma Progression and Is an Effective Indicator for Met-Targeting Therapy. Genes & Cancer. 4(7-8). 247–260. 30 indexed citations
2.
Bromberg-White, Jennifer L., Louis C. Glazer, Robert G. Downer, et al.. (2013). Identification of VEGF-Independent Cytokines in Proliferative Diabetic Retinopathy Vitreous. Investigative Ophthalmology & Visual Science. 54(10). 6472–6472. 61 indexed citations
3.
Furge, Kyle, et al.. (2012). Renal Cell Carcinoma Deep Sequencing: Recent Developments. Current Oncology Reports. 14(3). 240–248. 11 indexed citations
4.
Furge, Kyle, Wenjiang Fu, Julia V. Busik, et al.. (2012). Gene expression in archived newborn blood spots distinguishes infants who will later develop cerebral palsy from matched controls. Pediatric Research. 73(1-4). 450–456. 20 indexed citations
5.
Ang, Mei‐Kim, Aye Aye Thike, Patrick Tan, et al.. (2010). Molecular classification of breast phyllodes tumors: validation of the histologic grading scheme and insights into malignant progression. Breast Cancer Research and Treatment. 129(2). 319–329. 34 indexed citations
6.
Hammers, Hans J., Henk M.W. Verheul, Brenda Salumbides, et al.. (2010). Reversible Epithelial to Mesenchymal Transition and Acquired Resistance to Sunitinib in Patients with Renal Cell Carcinoma: Evidence from a Xenograft Study. Molecular Cancer Therapeutics. 9(6). 1525–1535. 141 indexed citations
7.
Casey, Theresa, et al.. (2009). Molecular Signatures Reveal Circadian Clocks May Orchestrate the Homeorhetic Response to Lactation. PLoS ONE. 4(10). e7395–e7395. 32 indexed citations
8.
Zhao, Ping, Chong Gao, Karl Dykema, et al.. (2009). Repeated hepatocyte growth factor neutralizing antibody treatment leads to HGF/SF unresponsiveness in human glioblastoma multiforme cells. Cancer Letters. 291(2). 209–216. 6 indexed citations
9.
10.
Ding, Yan, Elissa A. Boguslawski, Bree D. Berghuis, et al.. (2008). Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcoma. Molecular Cancer Therapeutics. 7(3). 648–658. 29 indexed citations
11.
Chen, Jindong, Kunihiko Futami, David Petillo, et al.. (2008). Correction: Deficiency of FLCN in Mouse Kidney Led to Development of Polycystic Kidneys and Renal Neoplasia. PLoS ONE. 3(11). 22 indexed citations
12.
Bonte, Dorine, Charlotta Lindvall, Hongyu Liu, et al.. (2008). Cdc7-Dbf4 Kinase Overexpression in Multiple Cancers and Tumor Cell Lines Is Correlated with p53 Inactivation. Neoplasia. 10(9). 920–IN4. 106 indexed citations
13.
Chen, Jindong, Kunihiko Futami, David Petillo, et al.. (2008). Deficiency of FLCN in Mouse Kidney Led to Development of Polycystic Kidneys and Renal Neoplasia. PLoS ONE. 3(10). e3581–e3581. 104 indexed citations
14.
Hui, Zhouguang, Maria Tretiakova, Zhongfa Zhang, et al.. (2008). Radiosensitization by Inhibiting STAT1 in Renal Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 73(1). 288–295. 52 indexed citations
15.
Gao, Chong, Kyle Furge, Julie Koeman, et al.. (2007). Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations. Proceedings of the National Academy of Sciences. 104(21). 8995–9000. 112 indexed citations
16.
Yang, Ximing J., Jun Sugimura, Kristian T. Schafernak, et al.. (2006). Classification of Renal Neoplasms Based on Molecular Signatures. The Journal of Urology. 175(6). 2302–2306. 59 indexed citations
17.
Gray, Steven G., Chao Qian, Kyle Furge, Xiang Guo, & Bin Tean Teh. (2004). Microarray profiling of the effects of histone deacetylase inhibitors on gene expression in cancer cell lines. International Journal of Oncology. 24(4). 773–95. 78 indexed citations
18.
Yang, Ximing J., Jun Sugimura, Maria Tretiakova, et al.. (2004). Gene expression profiling of renal medullary carcinoma. Cancer. 100(5). 976–985. 58 indexed citations
19.
Lindvall, Charlotta, Kyle Furge, Magnus Björkholm, et al.. (2004). Combined genetic and transcriptional profiling of acute myeloid leukemia with normal and complex karyotypes.. PubMed. 89(9). 1072–81. 28 indexed citations
20.
Takahashi, Masayuki, Jun Sugimura, Ximing J. Yang, et al.. (2003). Gene Expression Profiling of Renal Cell Carcinoma and Its Implications in Diagnosis, Prognosis, and Therapeutics. Advances in cancer research. 89. 157–181. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chuifeng Fan Breakdown of academic impact, for papers by Jana Krošl Breakdown of academic impact, for papers by Miki Hashimura Breakdown of academic impact, for papers by Phillip J. Iaquinta Breakdown of academic impact, for papers by Debora Rasio Breakdown of academic impact, for papers by Kanji Hojo Breakdown of academic impact, for papers by Victor Stastny Breakdown of academic impact, for papers by Kiyomi O. Toyooka Breakdown of academic impact, for papers by R. V. Larocca Breakdown of academic impact, for papers by Abdullah Mahmood Ali
Rankless by CCL
2026